Ameritas Advisory Services LLC Has $3.87 Million Stock Position in iShares Biotechnology ETF (NASDAQ:IBB)

Ameritas Advisory Services LLC lessened its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 8.1% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 26,586 shares of the financial services provider’s stock after selling 2,334 shares during the period. Ameritas Advisory Services LLC’s holdings in iShares Biotechnology ETF were worth $3,871,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. James J. Burns & Company LLC raised its stake in iShares Biotechnology ETF by 20.4% during the 3rd quarter. James J. Burns & Company LLC now owns 2,051 shares of the financial services provider’s stock valued at $298,000 after purchasing an additional 347 shares during the period. Clarity Capital Partners LLC purchased a new position in shares of iShares Biotechnology ETF during the third quarter valued at $206,000. Quintet Private Bank Europe S.A. grew its holdings in shares of iShares Biotechnology ETF by 20.7% during the third quarter. Quintet Private Bank Europe S.A. now owns 14,752 shares of the financial services provider’s stock valued at $2,148,000 after buying an additional 2,533 shares in the last quarter. Kanawha Capital Management LLC raised its position in iShares Biotechnology ETF by 20.6% during the third quarter. Kanawha Capital Management LLC now owns 8,384 shares of the financial services provider’s stock valued at $1,221,000 after buying an additional 1,432 shares during the period. Finally, Blue Square Asset Management LLC lifted its stake in iShares Biotechnology ETF by 3.0% in the 3rd quarter. Blue Square Asset Management LLC now owns 19,902 shares of the financial services provider’s stock worth $2,898,000 after acquiring an additional 580 shares in the last quarter. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Performance

Shares of NASDAQ IBB opened at $145.06 on Wednesday. iShares Biotechnology ETF has a one year low of $113.56 and a one year high of $150.57. The business has a 50-day moving average price of $144.86 and a two-hundred day moving average price of $140.84.

iShares Biotechnology ETF Announces Dividend

The business also recently declared a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were issued a dividend of $0.2005 per share. The ex-dividend date of this dividend was Wednesday, September 25th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.